" class="no-js "lang="en-US"> Deborah Waterhouse - Medtech Alert
Thursday, August 21, 2025
Deborah Waterhouse

Deborah Waterhouse

About Deborah Waterhouse

A business leader who has managed P&Ls across multiple geographies with extensive Government Relations experience. A strong leader who has worked across many cultures with a track record of developing clear strategies, strong alignment and excellent execution driving shareholder and customer value. Extensive M&A experience. I am passionate about working in healthcare and am motivated every day by the opportunity to serve our customers and make a difference to patients. I have been a Non Executive Director of Schroders since March 2019.

Related Story

ViiV Healthcare Announces US FDA Approval of Apretude (Cabotegravir Extended-release Injectable Suspension), the First and Only Long-acting Injectable Option for HIV Prevention

December 21 2021

ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (GSK), with Pfizer […]

ViiV Healthcare New Drug Application for Long-Acting Cabotegravir for Prevention of HIV

May 4 2021

ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (“GSK”), with Pfizer […]